GLP-1 weight loss drugs: Renowned cardiovascular surgeon Dr. Naresh Trehan has issued a stern warning against the unsupervised use of GLP-1...

Affordable semaglutide generics are coming to India. This drug helps with diabetes and weight loss. Millions need it for health issues. How...

Don’t buy a stock, buy a business, says our headline. It’s not as easy as it sounds. But it’s not too difficult either. While there are sev...

With US President Trump, nothing can be ruled out. But, for now at least, Indian pharma companies can breathe a little easier. The 100% tar...

Novo Nordisk is set to discontinue some forms of its Mixtard insulin, including pen and cartridge versions, in India, coinciding with the a...

While BofA remained overweight on select domestic cyclicals such as industrials, financials and automobile stocks, it has marginally trimme...

Madam Speaker, Madam Vice President, our First Lady and Second Gentleman. Members of Congress and the Cabinet. Justices of the Supreme Cour...

The bill will still have to clear the Senate, where revisions are nearly certain. But Democrats are aiming to get it to Biden's desk by Chr...

Mylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.

In an interview with ET, Sharma talked about why the changes are important for India and how the firm is moving into this nascent-but-growi...